http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8080539-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f9738e76832cd689a35b39137870ac7b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3f854fb0e5b8c7bcfb85cbd600f46b31
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-353
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
filingDate 2010-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2011-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_467b755d5e0e1974340e5bf143613b16
publicationDate 2011-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-8080539-B2
titleOfInvention Method of treating human preeclampsia employing resibufagenin
abstract A method of treating preeclampsia including administering a therapeutically effective dose of resibufagenin to a patient having preeclampsia. Effecting the determination of the presence of preeclampsia may be by determining whether there has been a substantial elevation in marinobufagenin which may be blood-derived or urine-derived and if such elevation does exist, concluding that preeclampsia does exist. The method may advantageously be practiced by employing urine, blood serum or blood plasma as the body specimen containing the protein in determining whether a patient has preeclampsia. In another embodiment, bufodienolide derivatives other than resibufagenin may be employed in lieu of thereof or in combination therewith. In another embodiment, resibufagenin analogues may be employed in the treatment of preeclampsia.
priorityDate 2004-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5756500-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6306845-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5770376-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247861326
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3035030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66755609
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12358887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21140732
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226708781
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135838917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226709027
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226709028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226941891
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66755607
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247390257
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226941892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226709029
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10104
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66755608

Total number of triples: 35.